The Rush Cancer Center is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
The Rush Cancer Center has participated in 1 clinical trials.
Therapeutic areas: Mantle Cell Lymphoma.
Sponsors: Millennium Pharmaceuticals, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Rush Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Rush Cancer Center has 1 clinical trials on record. Their work covers Mantle Cell Lymphoma.
The Rush Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.